Literature DB >> 23606503

Receptor-specific delivery of protein antigen to dendritic cells by a nanoemulsion formed using top-down non-covalent click self-assembly.

B J Zeng1, Y P Chuan, B O'Sullivan, I Caminschi, M H Lahoud, R Thomas, A P J Middelberg.   

Abstract

A new class of targeted and immune-evading nanocarrier made using only biological components and facile processes is assembled in a bottom-up fashion. Simple top-down sequential addition of immune-evading or receptor-specific antibody elements conjugated to biosurfactant protein DAMP4 promotes self-assembly at an interface previously formed in the presence of peptide surfactant AM1, leading to a functional display at the interface through non-covalent molecular self-assembly.
Copyright © 2013 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  antigens; dendritic cells; drug delivery; proteins; receptor specific; targeted delivery

Mesh:

Substances:

Year:  2013        PMID: 23606503     DOI: 10.1002/smll.201300078

Source DB:  PubMed          Journal:  Small        ISSN: 1613-6810            Impact factor:   13.281


  6 in total

1.  Self-adjuvanting nanoemulsion targeting dendritic cell receptor Clec9A enables antigen-specific immunotherapy.

Authors:  Bijun Zeng; Anton Pj Middelberg; Adrian Gemiarto; Kelli MacDonald; Alan G Baxter; Meghna Talekar; Davide Moi; Kirsteen M Tullett; Irina Caminschi; Mireille H Lahoud; Roberta Mazzieri; Riccardo Dolcetti; Ranjeny Thomas
Journal:  J Clin Invest       Date:  2018-04-09       Impact factor: 14.808

Review 2.  Toxoid Vaccination against Bacterial Infection Using Cell Membrane-Coated Nanoparticles.

Authors:  Pavimol Angsantikul; Ronnie H Fang; Liangfang Zhang
Journal:  Bioconjug Chem       Date:  2017-12-27       Impact factor: 4.774

Review 3.  Is There an Optimal Formulation and Delivery Strategy for Subunit Vaccines?

Authors:  Sharan Bobbala; Sarah Hook
Journal:  Pharm Res       Date:  2016-07-05       Impact factor: 4.580

4.  Toll-like receptor 3-induced immune response by poly(d,l-lactide-co-glycolide) nanoparticles for dendritic cell-based cancer immunotherapy.

Authors:  Hee Dong Han; Yeongseon Byeon; Tae Heung Kang; In Duk Jung; Jeong-Won Lee; Byung Cheol Shin; Young Joo Lee; Anil K Sood; Yeong-Min Park
Journal:  Int J Nanomedicine       Date:  2016-11-02

Review 5.  Biopharmaceutical insights of particulate emulsified systems - a prospective overview.

Authors:  Jyothshna Devi Katamreddy; Prasanna Raju Yalavarthi; Subba Rao D; Sowjanya Battu; Jaya Preethi Peesa
Journal:  Lipids Health Dis       Date:  2018-05-10       Impact factor: 3.876

6.  Using elongated microparticles to enhance tailorable nanoemulsion delivery in excised human skin and volunteers.

Authors:  Miko Yamada; Hossam Tayeb; Hequn Wang; Nhung Dang; Yousuf H Mohammed; Sam Osseiran; Paul J Belt; Michael S Roberts; Conor L Evans; Frank Sainsbury; Tarl W Prow
Journal:  J Control Release       Date:  2018-09-15       Impact factor: 9.776

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.